Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets - PubMed

Affiliations

• PMID: 16251775

Review

Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets

Ramakrishna U Rao. Indian J Med Res. 2005 Sep.

Abstract

The parasitic nematodes Wuchereria bancrofti, Brugia malayi and B. timori cause a dreadful disease in humans known as lymphatic filariasis, which afflicts more than 120 million people worldwide. As per recent epidemiologic estimates on prevalence of W. bancrofti and B. malayi, about 428 million people are at risk, with 28 million microfilaria carriers and 21 million clinical cases spread out in 13 States and 5 Union Territories of India. The Indian subcontinent that comprises Bangladesh, India, Maldives, Nepal and Sri Lanka harbours 50 per cent of the world's lymphatic filarial disease burden. Recently, an endobacterium of Wolbachia species that belongs to the family Rickettsiaceae was found in all life cycle stages of these nematodes and the transmission is exclusively vertical through the embryonic stages of the female worms. People with filariasis have been exposed to these Wolbachia bacteria or their proteins by the natural killing of parasites. Wolbachia have also been identified occasionally in body fluids of infected patients. Evidence suggests that these Wolbachia are mutualistic symbionts and can be cured from the nematodes by several antibiotics having antirickettsial properties. Treatment of nematodes with tetracyclines affect Wolbachia and they get cleared from worm tissues; and this elimination causes reproductive abnormalities in worms and affect worm's embryogenesis, resulting in sterility. Although it is impractical, prolonged treatment with doxycycline significantly reduces the numbers of microfilaria in circulation, which is an important strategy to control transmission of filariasis by mosquito vectors. In this review, the current knowledge of Wolbachia as a drug target and potential ways to reduce the infection through anti-Wolbachia treatments is discussed.

Similar articles

• Filamentation temperature-sensitive protein Z (FtsZ) of Wolbachia, endosymbiont of Wuchereria bancrofti: a potential target for anti-filarial chemotherapy.

  Sharma R, Hoti SL, Vasuki V, Sankari T, Meena RL, Das PK. Sharma R, et al. Acta Trop. 2013 Mar;125(3):330-8. doi: 10.1016/j.actatropica.2012.12.004. Epub 2012 Dec 19. Acta Trop. 2013. PMID: 23262214

• Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.

  Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Büttner DW. Hoerauf A, et al. Med Microbiol Immunol. 2003 Nov;192(4):211-6. doi: 10.1007/s00430-002-0174-6. Epub 2003 Mar 5. Med Microbiol Immunol. 2003. PMID: 12684759 Clinical Trial.

• Antibiotics for the treatment of onchocerciasis and other filarial infections.

  Hoerauf A, Adjei O, Büttner DW. Hoerauf A, et al. Curr Opin Investig Drugs. 2002 Apr;3(4):533-7. Curr Opin Investig Drugs. 2002. PMID: 12090719 Review.

• Wolbachia bacterial endosymbionts of filarial nematodes.

  Taylor MJ, Bandi C, Hoerauf A. Taylor MJ, et al. Adv Parasitol. 2005;60:245-84. doi: 10.1016/S0065-308X(05)60004-8. Adv Parasitol. 2005. PMID: 16230105 Review.

Cited by

• Improved efficacy of tetracycline by acaciasides on Dirofilaria immitis.

  Datta S, Maitra S, Gayen P, Sinha Babu SP. Datta S, et al. Parasitol Res. 2009 Sep;105(3):697-702. doi: 10.1007/s00436-009-1441-x. Epub 2009 May 9. Parasitol Res. 2009. PMID: 19430817

• Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.

  Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ. Tamarozzi F, et al. Clin Microbiol Rev. 2011 Jul;24(3):459-68. doi: 10.1128/CMR.00057-10. Clin Microbiol Rev. 2011. PMID: 21734243 Free PMC article. Review.

• Development of a multiplex qPCR-based approach for the diagnosis of Dirofilaria immitis, D. repens and Acanthocheilonema reconditum.

  Laidoudi Y, Davoust B, Varloud M, Niang EHA, Fenollar F, Mediannikov O. Laidoudi Y, et al. Parasit Vectors. 2020 Jun 22;13(1):319. doi: 10.1186/s13071-020-04185-0. Parasit Vectors. 2020. PMID: 32571427 Free PMC article.

• Effect of Certain Antibiotics Against Filarial Parasite Brugia malayi In Vitro: Possible Role of Oxidative Stress.

  Mahajan RS, Veerpathran A, Dakshinamoorthy G, Sharma RD, Goswami K, Reddy MV. Mahajan RS, et al. Indian J Clin Biochem. 2010 Oct;25(4):362-6. doi: 10.1007/s12291-010-0068-0. Epub 2010 Aug 25. Indian J Clin Biochem. 2010. PMID: 21966105 Free PMC article.

• Cloning and sequence analysis of partial genomic DNA coding for HtrA-type serine protease of Wolbachia from human lymphatic filarial parasite, Wuchereria bancrofti.

  Dhamodharan R, Hoti S, Sivapragasam G, Das M. Dhamodharan R, et al. Trop Parasitol. 2011 Jul;1(2):76-82. doi: 10.4103/2229-5070.86935. Trop Parasitol. 2011. PMID: 23508470 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program